Uveitis, Anterior
Showing 76 - 100 of 3,917
Rhegmatogenous Retinal Detachment Trial in Boston (Pars plana vitrectomy, Triamcinolone Acetonide 40mg/mL, Moxifloxacin 0.5% or
Recruiting
- Rhegmatogenous Retinal Detachment
- Pars plana vitrectomy
- +4 more
-
Boston, MassachusettsMassachusetts Eye and Ear
Jul 26, 2022
Non-Infectious Uveitis Trial in Worldwide (FAI insert, Sham injection)
Completed
- Non-Infectious Uveitis
- FAI insert
- Sham injection
-
Beverly Hills, California
- +33 more
Mar 5, 2021
Uveitis, Scleritis Trial in Saint Louis (tofacitinib)
Unknown status
- Uveitis
- Scleritis
-
Saint Louis, MissouriWashington University in Saint Louis
Jan 7, 2021
A Study of Adalimumab in Acute Vogt-Koyanagi-Harada Disease
Recruiting
- Vogt-Koyanagi-Harada Disease
- Adalimumab
-
Tianjin, Tianjin, ChinaTianjin Medical University Eye Hospital
Oct 19, 2022
Cataract, Ocular Inflammation, Ocular Hypertension Trial (Intraoperative delivery of medication, Kenalog (Triamcinolone),
Not yet recruiting
- Cataract
- +3 more
- Intraoperative delivery of medication, Kenalog (Triamcinolone)
- Topical post-operative eyedrops, Prednisolone acetate
- (no location specified)
Aug 4, 2022
Eye Diseases, Uveitis Trial in Leuven (Abatacept 125 MG/ML Prefilled Syringe)
Active, not recruiting
- Eye Diseases
- Uveitis
- Abatacept 125 MG/ML Prefilled Syringe
-
Leuven, Vlaams-Brabant, BelgiumUZLeuven
Jan 26, 2023
Age-related Cataract, Phacoemulsification Trial in Ciudad de mexico (Sodium hyaluronate 3%)
Completed
- Age-related Cataract
- Phacoemulsification
- Sodium hyaluronate 3%
-
Ciudad de mexico, MexicoSalaUno Salud, S.A.P.I. de C.V.
Dec 22, 2021
Anterior Uveitis Trial in Norfolk (Dexamethasone Phosphate Ophthalmic Solution, Prednisolone Acetate Ophthalmic (1%))
Completed
- Anterior Uveitis
- Dexamethasone Phosphate Ophthalmic Solution
- Prednisolone Acetate Ophthalmic (1%)
-
Norfolk, VirginiaVirginia Eye Consultants
Jul 24, 2018
Vitreoretinal Surgery, Ocular Inflammation, Post-operative Pain Trial in Cleveland (Dexamethasone Ophthalmic Insert,
Enrolling by invitation
- Vitreoretinal Surgery
- +3 more
- Dexamethasone Ophthalmic Insert
- Prednisolone Acetate 1% Oph Susp
-
Cleveland, OhioCole Eye Institute, Cleveland Clinic
Feb 24, 2022
Acute Anterior Uveitis Trial (LME636 60 mg/mL ophthalmic solution, Dexamethasone 0.1% ophthalmic solution, LME636 Vehicle)
Completed
- Acute Anterior Uveitis
- LME636 60 mg/mL ophthalmic solution
- +2 more
- (no location specified)
May 31, 2018
Retinitis Pigmentosa, Stem Cell Transplant Trial in Istanbul (Stem cell implantation)
Completed
- Retinitis Pigmentosa
- Stem Cell Transplant
- Stem cell implantation
-
Istanbul, TurkeyAcıbadem University
Jan 25, 2023
Glaucoma, Cataract Trial in Tehran (Non-penetrating deep sclerectomy and phacoemulsification and autotransplantation of anterior
Active, not recruiting
- Glaucoma
- Cataract
- Non-penetrating deep sclerectomy and phacoemulsification and autotransplantation of anterior lens capsule
- Non-penetrating deep sclerectomy and phacoemulsification
-
Tehran, Iran, Islamic Republic ofOphthalmic Research Center
Jun 7, 2023
Pathogen Detection in Infectious Uveitis
Recruiting
- Infectious Panuveitis
- Infectious Iridocyclitis
-
Shanghai, ChinaXinhua Hospital
Aug 20, 2020
Corticosteroid Combining Noncorticosteroid Systemic
Recruiting
- Vogt Koyanagi Harada Disease (VKH)
- noncorticosteroid systemic immunomodulatory therapy (NCSIT)
-
Guangzhou, Guangdong, ChinaZhongshan Ophthalmic Center
Nov 3, 2021
Glaucoma Following Surgery Trial in Memphis (DEXTENZA, Topical Dexamethasone)
Not yet recruiting
- Glaucoma Following Surgery
- DEXTENZA
- Topical Dexamethasone
-
Memphis, TennesseeHamilton Eye Institute
Nov 9, 2021
Non-infectious Uveitis Trial (care strategy)
Not yet recruiting
- Non-infectious Uveitis
- care strategy
- (no location specified)
Jun 26, 2023
Non Arteritic Ischemic Optic Neuropathy Trial in Valladolid (intravitreal injection of MSV)
Active, not recruiting
- Non Arteritic Ischemic Optic Neuropathy
- intravitreal injection of MSV
-
Valladolid, SpainIOBA - Applied Ophthalmobiology Institute
Apr 5, 2021
Minocycline, Uveitis, Retinal Degeneration Trial in Guangzhou (minocycline)
Recruiting
- Minocycline
- +2 more
-
Guangzhou, Guangdong, ChinaZhongshan Ophthalmic Center
Jul 24, 2022
Uveitis, Lymphoma, NK-Cell Lymphoma Trial in Lyon (Blood sample)
Recruiting
- Uveitis
- +2 more
- Blood sample
-
Lyon, France
- +1 more
Dec 23, 2022
Cataract, Surgery, Compliance, Patient Trial in San Francisco (Dropless Regimen, Standard Regimen)
Recruiting
- Cataract
- +4 more
- Dropless Regimen
- Standard Regimen
-
San Francisco, CaliforniaZuckerberg San Francisco General Hospital and Trauma Center (ZSF
May 31, 2022
Glaucoma Following Surgery Trial in Montréal (Topical infliximab, No topical infliximab)
Recruiting
- Glaucoma Following Surgery
- Topical infliximab
- No topical infliximab
-
Montréal, Quebec, CanadaCentre Hospitalier de l'Université de Montréal
Jul 4, 2022
Uveitis, Anterior Uveitis, Intermediate Uveitis Trial in Saint Petersburg (H.P. ACTHAR SUBCUTANEOUS GEL INJECTION)
Completed
- Uveitis
- +5 more
- H.P. ACTHAR SUBCUTANEOUS GEL INJECTION
-
Saint Petersburg, FloridaTampa Bay Uveitis Center
Jun 29, 2018
Wet Macular Degeneration Trial in Prague (Aflibercept 40 MG/ML [Eylea], Brolucizumab-Dbll 120 MG/ML [Beovu], Ranibizumab 6 MG/ML
Withdrawn
- Wet Macular Degeneration
- Aflibercept 40 MG/ML [Eylea]
- +2 more
-
Prague, CzechiaDepartment of Ophthalmology, Faculty hospital Kralovske Vinohrad
Aug 7, 2022
Lyon Uveitis Study
Recruiting
- Uveitis
- No specific intervention. Collection of clinical data
-
Lyon, FranceDepartment of Internal Medicine, Croix-Rousse Hospital, Hospices
Mar 18, 2022
Uveitis, Uveitis, Posterior, Uveitis, Intermediate Trial in Waltham (Sham Injector, FAI Insert)
Active, not recruiting
- Uveitis
- +2 more
- Sham Injector
- FAI Insert
-
Waltham, MassachusettsEyePoint Study Site
Dec 20, 2022